https://www.fiercebiotech.com/biotech/roivant-lines-up-3b-upfront-sumitomo-dainippon-deal
Roivant lines up $3B upfront in Sumitomo Dainippon deal | Fierce Biotech
Sep 6, 2019 - Sumitomo Dainippon Pharma is set to
roivantlines3bupfront
https://www.financialcontent.com/article/marketminute-2026-4-2-roivant-and-immunovant-solidify-market-leadership-as-brepocitinib-and-fcrn-programs-hit-critical-clinical-milestones
Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical...
The biotechnology sector witnessed a seismic shift this week as Roivant Sciences (Nasdaq: ROIV) and its subsidiary Immunovant (Nasdaq: IMVT) reported a series...
market leadership
https://www.gsk.com/en-gb/media/press-releases/roivant-subsidiary-dermavant-sciences-signs-agreement-with-gsk-to-purchase-rights-to-tapinarof/
Roivant subsidiary Dermavant Sciences signs agreement with GSK to purchase rights to tapinarof | GSK
GSK today announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof.
https://www.fiercebiotech.com/medtech/roivant-sciences-to-absorb-silicon-therapeutics-into-its-vantai-outfit-450m-deal
Roivant Sciences to absorb Silicon Therapeutics with $450M-plus deal | Fierce Biotech
Feb 26, 2021 - Roivant Sciences has moved to take molecule designer Silicon Therapeutics underneath its corporate umbrella in a deal worth $450 million or more that wi
roivant sciences
https://www.prnewswire.com/news-releases/roivant-provides-updates-for-pivotal-breathe-clinical-trial-evaluating-gimsilumab-in-covid-19-patients-for-the-prevention-and-treatment-of-acute-respiratory-distress-syndrome-301058738.html
Roivant Provides Updates for Pivotal BREATHE Clinical Trial Evaluating Gimsilumab in COVID-19...
/PRNewswire/ -- Roivant Sciences today announced several updates for its adaptive, randomized, double-blind, placebo-controlled, multi-center pivotal BREATHE...
https://www.insidermonkey.com/blog/institutional-investors-are-betting-on-roivant-sciences-nasdaqroiv-1307353/
Institutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV) - Insider Monkey
The healthcare industry is considered to be a fairly defensive sector due to its need.
institutional investorsroivant sciencesbetting
https://www.fxempire.com/stocks/roiv
ROIV: Roivant Sciences Ltd. Common Shares Stock Price, Quote, Forecasts & News | FXEmpire
Stay up-to-date with ROIV stock: Get live Roivant Sciences Ltd. Common Shares prices, real-time quotes, interactive charts, and key statistics. Dive into...
roivant sciences ltdcommon shares
https://www.flexjobs.com/remote-jobs/company/roivant
Roivant - Remote Work From Home Jobs & Careers | FlexJobs
Find remote work from home jobs and careers with Roivant. Get a better remote job search with FlexJobs today!
work from home jobsroivantremotecareersflexjobs
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-roiv/roivant-sciences/news/how-investors-may-respond-to-roivant-sciences-roiv-positive?ref=labs.ainvest.com
How Investors May Respond To Roivant Sciences (ROIV) Positive Phase 3 Results for Brepocitinib in...
Earlier this month, Roivant Sciences and Priovant Therapeutics announced positive Phase 3 results for brepocitinib in dermatomyositis, showing significant...
https://www.mql5.com/en/quotes/stocks/roiv
ROIV (Roivant Sciences Ltd): Stock Prices, Quotes & Online Live Charts
ROIV exchange rate has changed by -1.87% for today. During the day, the instrument was traded at a low of 27.8800 and at a high of 28.8600
roivant sciences ltdstock pricesonline livequotescharts
https://uberant.com/article/1421806-recently-available-strides-with-the-online-business-associated-with-roivant-sciences/
RECENTLY AVAILABLE STRIDES WITH THE ONLINE BUSINESS ASSOCIATED WITH ROIVANT SCIENCES
CURRENT UPGRADES WHILE IN THE COMPANY FROM ROIVANT SCIENCES - Roivant Sciences Organization can be a biotechnology industry focused on applying te
with theonline businessrecentlyavailablestrides
https://www.institutionalinvestor.com/article/2bsy8ykgtvgpxvqtguvpc/portfolio/the-morning-brief-viking-makes-private-investment-in-roivant
The Morning Brief: Viking Makes Private Investment in Roivant | Institutional Investor
the morningprivate investmentbriefvikingmakes
https://www.globenewswire.com/news-release/2025/08/11/3130765/0/en/Roivant-Reports-Financial-Results-for-the-First-Quarter-Ended-June-30-2025-and-Provides-Business-Update.html?ref=labs.ainvest.com
Roivant Reports Financial Results for the First Quarter
BASEL, Switzerland and LONDON and NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the first...
financial resultsfor theroivantreportsfirst
https://finviz.com/quote?t=ROIV
ROIV - Roivant Sciences Ltd Stock Price and Quote
ROIV - Roivant Sciences Ltd - Stock screener for investors and traders, financial visualizations.
roivant sciences ltdstock pricequote
https://www.fiercebiotech.com/biotech/roivant-avoids-autoimmune-pipeline-crisis-next-gen-fcrn-inhibitor-aces-early-biomarker-test
Roivant FcRn inhibitor avoids cholesterol problem, shares spike
Sep 26, 2023 - Immunovant's next-gen FcRn inhibitor was found to reduce immunoglobulin G levels without increases in cholesterol or decreases in albumin levels.
roivantfcrninhibitoravoidscholesterol
https://www.home.saxo/nl-be/markets/stocks/roiv-xnas
Roivant Sciences Limited aandeel | Saxo Bank
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
roivant scienceslimitedaandeelsaxobank
https://robinhood.com/us/en/stocks/ROIVW/
Roivant Sciences Ltd. Warrant: ROIVW Stock Price Quote & News | Robinhood
You can watch ROIVW and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying...
roivant sciences ltdstock pricewarrantquotenews
https://www.macrotrends.net/stocks/charts/ROIV/roivant-sciences/operating-margin
Roivant Sciences Operating Margin 2021-2025 | ROIV | MacroTrends
Current and historical operating margin for Roivant Sciences (ROIV) over the last 10 years. The current operating profit margin for Roivant Sciences as of...
roivant sciencesoperating margin20212025macrotrends
https://www.home.saxo/en-ch/markets/stocks/roiv-xnas
Roivant Sciences Limited stock | Saxo Bank Switzerland
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
roivant scienceslimited stocksaxo bankswitzerland
https://www.benzinga.com/markets/equities/23/10/35368282/roche-buys-pfizer-roivant-sciences-televant-in-7-1b-deal
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal - ROCHE HOLDING LTD S/ADR by Roche...
Oct 23, 2023 - Roche Holding AG (OTC: RHHBY) inked a deal to acquire
https://informaconnect.com/life-sciences-accounting-reporting-congress/speakers/jenni-humes/
Jenni Humes - Roivant | Life Sciences Accounting & Reporting Congress Speaker
life sciencesjennihumesroivantaccounting
https://www.fxempire.com/stocks/roiv/profile
ROIV: Roivant Sciences Ltd. Common Shares Company Profile & Statistics | FXEmpire
Dive into the Roivant Sciences Ltd. Common Shares (ROIV) company profile. Key financial ratios, comprehensive company statistics, and essential ROIV data, all...
roivant sciences ltdcommon sharescompany profilestatistics
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-roiv/roivant-sciences/news/roivant-sciences-full-year-2025-earnings-eps-beats-expectati
Roivant Sciences Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St News
Roivant Sciences ( NASDAQ:ROIV ) Full Year 2025 Results Key Financial Results Revenue: US$29.1m (down 77% from FY...
https://menafn.com/1109653236/Roivant-And-Priovant-To-Host-Investor-Video-Conference-At-100-PM-ET-On-Tuesday-June-17-On-Brepocitinib-And-The-Unmet-Medical-Need-In-Dermatomyositis
Roivant And Priovant To Host Investor Video Conference At 1:00 PM ET On Tuesday, June 17 On...
Roivant And Priovant To Host Investor Video Conference At 1:00 PM ET On Tuesday, June 17 On Brepocitinib And The Unmet Medical Need In Dermatomyositis. BASEL,...